JARON WINSTON: Open Payments
NPI 1568463420 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 25 payments from 13 companies in 2025. Trend: 2023 $678 · 2024 $2,169 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $164 |
| Lundbeck LLC | 5 | $108 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| ACADIA Pharmaceuticals Inc | 4 | $75 |
| Eisai Inc. | 2 | $56 |
| ABBVIE INC. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: REXULTI, SPRAVATO, NUPLAZID, Leqembi, VRAYLAR, AUSTEDO XR, Auvelity, INGREZZA.
Industry payments across TX — which companies pay providers there.
